Personalization of Clotting Factor VIII Replacement Therapy Based on Population Pharmacokinetics in Adult Patients with Severe Hemophilia a Who Frequently Switch Factor VIII Concentrates

被引：0
|
作者：
Windyga, Jerzy [1 ]
Odnoczko, Edyta [2 ]
Stefanska-Windyga, Ewa [3 ]
Baran, Beata [2 ]
Sikorska, Anna [3 ]
Gorska-Kosicka, Magdalena [4 ]
Zawilski, Janusz [5 ]
Letowska, Magdalena [6 ]
机构：
[1] Inst Hematol & Transfus Med, Dept Hemostasis Disorders & Internal Med, Lab Hemostasis & Metab Dis, Warsaw, Poland
[2] Inst Hematol & Transfus Med, Lab Hemostasis & Metab Dis, Warsaw, Poland
[3] Inst Hematol & Transfus Med, Clin Hemostasis Disorders, Warsaw, Poland
[4] Inst Hematol & Transfus Med, Dept Hemostasis Disorders & Internal Med, Warsaw, Poland
[5] INTERLAB, Poznan, Poland
[6] Inst Hematol & Transfus Med, Dept Transfus Med, Warsaw, Poland
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-164998
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8451 / 8452
页数：2
相关论文
共 50 条
  • [11] Is it dangerous to treat previously untreated patients with severe hemophilia A with recombinant factor VIII concentrates?
    Drillaud, Nicolas
    Lienhart, Anne
    Babuty, Antoine
    Dargaud, Yesim
    Chamouard, Valerie
    Trossaert, Marc
    Fouassier, Marc
    Rugeri, Lucia
    Sigaud, Marianne
    Lefranc, Carole
    Ternisien, Catherine
    Meunier, Sandrine
    HAEMOPHILIA, 2020, 26 : 67 - 67
  • [12] Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A
    Chen Zhenping
    Huang Kun
    Li Gang
    Zhen Yingzi
    Wu Xinyi
    Ai Di
    Liu Guoqing
    Li Zekun
    Alfonso Iorio
    Wu Runhui
    儿科学研究（英文）, 2021, 05 (01) : 38 - 45
  • [13] EVALUATION OF FACTOR-VIII PHARMACOKINETICS IN HEMOPHILIA PATIENTS AFTER FACTOR-VIII CONCENTRATE INFUSION
    TAPONBRETAUDIERE, J
    GAZENGEL, C
    FISCHER, AM
    TORCHET, MF
    GUERDER, C
    JOSSO, F
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 210 - 210
  • [14] Factor VIII haplotypes in severe hemophilia A patients in India
    Patricia Pinto
    Kanjaksha Ghosh
    Shrimati Shetty
    Annals of Hematology, 2013, 92 : 999 - 1000
  • [15] Factor VIII haplotypes in severe hemophilia A patients in India
    Pinto, Patricia
    Ghosh, Kanjaksha
    Shetty, Shrimati
    ANNALS OF HEMATOLOGY, 2013, 92 (07) : 999 - 1000
  • [16] Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A
    Powell, J. S.
    Nugent, D. J.
    Harrison, J. A.
    Soni, A.
    Luk, A.
    Stass, H.
    Gorina, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (02) : 277 - 283
  • [17] CLINICAL PHARMACOKINETICS OF FACTOR-VIII IN PATIENTS WITH CLASSIC HEMOPHILIA
    MESSORI, A
    LONGO, G
    MATUCCI, M
    MORFINI, M
    FERRINI, PLR
    CLINICAL PHARMACOKINETICS, 1987, 13 (06) : 365 - 380
  • [18] INCIDENCE OF INHIBITORS IN PATIENTS WITH SEVERE AND MODERATE HEMOPHILIA-A TREATED WITH FACTOR-VIII CONCENTRATES
    SCHWARZINGER, I
    PABINGER, I
    KORNINGER, C
    HASCHKE, F
    KUNDI, M
    NIESSNER, H
    LECHNER, K
    AMERICAN JOURNAL OF HEMATOLOGY, 1987, 24 (03) : 241 - 245
  • [19] Safety and efficacy of factor VIII concentrates replacement in Senegalese patients
    Diop, S.
    Seck, M.
    Abdoulaye, O.
    Salaou, C.
    Thiam, D.
    Diakhate, L.
    HAEMOPHILIA, 2008, 14 : 13 - 13
  • [20] Immunogenicity of factor VIII concentrates in patients with hemophilia: the next sensible step
    Van der Bom, Johanna G.
    Gouw, Samantha C.
    Van den Berg, H. Marijke
    BLOOD, 2007, 110 (08) : 3085 - 3085
12345